Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 8 | 2023 | 190 | 2.670 |
Why?
|
| Neonatology | 3 | 2024 | 51 | 1.890 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2024 | 78 | 0.890 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2023 | 319 | 0.870 |
Why?
|
| Neonatologists | 2 | 2023 | 18 | 0.860 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2018 | 628 | 0.810 |
Why?
|
| Work Performance | 1 | 2022 | 14 | 0.770 |
Why?
|
| Qualitative Research | 1 | 2024 | 548 | 0.740 |
Why?
|
| Patient Care Team | 2 | 2022 | 547 | 0.630 |
Why?
|
| Infant, Newborn | 12 | 2023 | 8182 | 0.540 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2017 | 80 | 0.530 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 2 | 2018 | 401 | 0.530 |
Why?
|
| Hypothermia, Induced | 1 | 2017 | 166 | 0.510 |
Why?
|
| Glucocorticoids | 2 | 2016 | 385 | 0.480 |
Why?
|
| Positive-Pressure Respiration | 1 | 2015 | 82 | 0.470 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2015 | 94 | 0.470 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2016 | 79 | 0.460 |
Why?
|
| Infant, Premature | 6 | 2022 | 814 | 0.450 |
Why?
|
| Hemorrhage | 1 | 2017 | 466 | 0.440 |
Why?
|
| Pulmonary Surfactants | 1 | 2014 | 43 | 0.440 |
Why?
|
| Diuretics | 1 | 2015 | 171 | 0.440 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 316 | 0.410 |
Why?
|
| Racism | 1 | 2022 | 35 | 0.380 |
Why?
|
| Hypercalcemia | 1 | 2010 | 39 | 0.350 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 462 | 0.340 |
Why?
|
| Infant, Premature, Diseases | 1 | 2022 | 241 | 0.340 |
Why?
|
| Failure to Thrive | 1 | 2010 | 90 | 0.340 |
Why?
|
| Lung | 2 | 2016 | 1491 | 0.330 |
Why?
|
| Premature Birth | 1 | 2022 | 384 | 0.300 |
Why?
|
| Infant, Extremely Premature | 2 | 2022 | 84 | 0.260 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2021 | 38 | 0.250 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 240 | 0.250 |
Why?
|
| Hyperoxia | 1 | 2017 | 129 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 2 | 2016 | 9 | 0.250 |
Why?
|
| Calcium | 1 | 2010 | 1098 | 0.240 |
Why?
|
| Dexamethasone | 2 | 2016 | 275 | 0.220 |
Why?
|
| Workload | 1 | 2024 | 148 | 0.210 |
Why?
|
| Humans | 16 | 2024 | 124793 | 0.210 |
Why?
|
| Interviews as Topic | 1 | 2024 | 377 | 0.210 |
Why?
|
| Female | 11 | 2024 | 66553 | 0.200 |
Why?
|
| Leadership | 1 | 2024 | 228 | 0.200 |
Why?
|
| Smoking | 1 | 2017 | 1044 | 0.190 |
Why?
|
| Male | 10 | 2024 | 61283 | 0.190 |
Why?
|
| Morbidity | 1 | 2021 | 244 | 0.170 |
Why?
|
| Gestational Age | 3 | 2023 | 1161 | 0.170 |
Why?
|
| Ambulatory Care | 1 | 2022 | 387 | 0.160 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 672 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2022 | 262 | 0.160 |
Why?
|
| Infant | 5 | 2023 | 12482 | 0.150 |
Why?
|
| Pandemics | 2 | 2023 | 1105 | 0.140 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2016 | 58 | 0.140 |
Why?
|
| Anuria | 1 | 2017 | 13 | 0.140 |
Why?
|
| Physicians | 1 | 2023 | 582 | 0.140 |
Why?
|
| Infant Care | 1 | 2016 | 46 | 0.140 |
Why?
|
| Tracheostomy | 2 | 2016 | 193 | 0.130 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 135 | 0.130 |
Why?
|
| Fundoplication | 1 | 2015 | 66 | 0.120 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2014 | 6 | 0.110 |
Why?
|
| Administration, Inhalation | 1 | 2015 | 180 | 0.110 |
Why?
|
| Gastrostomy | 1 | 2015 | 85 | 0.110 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 91 | 0.110 |
Why?
|
| Pregnancy, Animal | 1 | 2014 | 76 | 0.110 |
Why?
|
| Oxygen | 1 | 2017 | 555 | 0.110 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3448 | 0.110 |
Why?
|
| Prevalence | 2 | 2021 | 2451 | 0.100 |
Why?
|
| Cross-Over Studies | 1 | 2014 | 312 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2014 | 148 | 0.100 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 3726 | 0.100 |
Why?
|
| Logistic Models | 1 | 2017 | 1810 | 0.100 |
Why?
|
| Disease Management | 1 | 2015 | 521 | 0.090 |
Why?
|
| Registries | 1 | 2017 | 1422 | 0.090 |
Why?
|
| Pregnancy | 3 | 2017 | 7172 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2015 | 435 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1354 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2016 | 3753 | 0.080 |
Why?
|
| Hospitals | 1 | 2022 | 398 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2023 | 4783 | 0.080 |
Why?
|
| Adult | 2 | 2024 | 29471 | 0.080 |
Why?
|
| Texas | 1 | 2017 | 3590 | 0.080 |
Why?
|
| Chorioamnionitis | 1 | 2017 | 42 | 0.070 |
Why?
|
| United States | 1 | 2022 | 10885 | 0.070 |
Why?
|
| Neonatal Sepsis | 1 | 2017 | 32 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4357 | 0.070 |
Why?
|
| Retrospective Studies | 3 | 2023 | 16299 | 0.070 |
Why?
|
| Perinatal Care | 1 | 2017 | 67 | 0.070 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 74 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 2903 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1929 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2017 | 145 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 229 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 4431 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1893 | 0.060 |
Why?
|
| Time Factors | 1 | 2014 | 6309 | 0.050 |
Why?
|
| Pregnancy Complications | 1 | 2017 | 507 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 134 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2021 | 35 | 0.050 |
Why?
|
| Child | 1 | 2022 | 24453 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 10272 | 0.050 |
Why?
|
| Incidence | 1 | 2017 | 3144 | 0.040 |
Why?
|
| Mice | 1 | 2014 | 17746 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3142 | 0.030 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2016 | 7 | 0.030 |
Why?
|
| Animals | 2 | 2016 | 34184 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 238 | 0.030 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2016 | 40 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 83 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 565 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2016 | 1010 | 0.030 |
Why?
|
| Biomarkers | 1 | 2017 | 3063 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12342 | 0.010 |
Why?
|